Jubilant Life Sciences announces price increase of 9% for Niacinamide
Jubilant Life Sciences Ltd has informed BSE regarding a Press Release dated June 12, 2014, titled, "Jubilant Life Sciences announces price increase of 9% for Niacinamide". Details as per Clause 20
Jubilant Life Sciences Ltd has informed BSE about the year ended March 31, 2014 as per Clause 20 of the Listing Agreement. IFC's $147.5 million Package to Jubilant Pharma to Expand Access to Affordable Pharmaceuticals
Jubilant Life Sciences Ltd has informed BSE regarding a Press Release dated May 26, 2014, titled "IFC's $147.5 million Package to Jubilant Pharma to Expand Access to Affordable Pharmaceuticals" Board recommends Dividend
Jubilant Life Sciences Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 26, 2014, inter alia, has recommended a dividend of Rs. 3 per equity shares of Rs. 1 fully paid up amounting to Rs. 5590 lacs, subject to approval in the Annual General Meeting. Presentation
Jubilant Life Sciences Ltd has submitted to BSE a copy of Presentation for the period ended March 31, 2014. Financial Results with Results Press Release & Auditors Report for March 31, 2014 (Audited)
Jubilant Life Sciences Ltd has informed BSE about the Financial Results, Results Press Release & a copy of the Auditors Report for the period ended March 31, 2014. Board to consider Dividend
Jubilant Life Sciences Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on May 26, 2014, inter alia, to consider:1. Audited Financial Results of the Company for the year ended March 31, 2014.2. Recommendation of Dividend for the Year ended March 31, 2014.Further, as per the Companys Insider Trading Code, the trading window for dealing in the securities of the Company would remain closed... Jubilant Life Sciences receives ANDA approval
Jubilant Life Sciences Ltd has informed BSE regarding a Press Release dated April 25, 2014 titled "Jubilant Life Sciences receives ANDA approval". Shareholding Pattern for March 31, 2014
Jubilant Life Sciences Ltd has informed BSE about the Shareholding Pattern for the Quarter ended March 31, 2014.